1.
Frontiers of Medicine
;
(4): 208-220, 2021.
Article
in English
| WPRIM
| ID: wpr-880965
ABSTRACT
New targeted therapies have been developed to overcome resistance to endocrine therapy (ET) and improve the outcome of HR